Biotechnology Development Fund II LP insider trades: Bioform Medical (BFRM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Biotechnology Development Fund II LP reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 19, 2010 | BFRM | ↓ Sell | 420,054 | $5.51 | $2.3M | By Biotechnology Development Fund II, L. | Jan 21, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Biotechnology Development Fund II LP's insider trades
Biotechnology Development Fund II LP is a 10% owner of Bioform Medical (BFRM). Since Jan 19, 2010, it has reported no open-market purchases and 1 sale worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BFRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.